Skip to main content
Premium Trial:

Request an Annual Quote

Reinhard Hiller, Jonathan Blackburn, Hessel Lindenbergh

Premium
Reinhard Hiller and Jonathan Blackburn have joined GenTel Biosciences’ scientific advisory board, the firm said this week.
 
Both scientists are involved in the Center for Proteomic and Genomic Research in Cape Town, South Africa, where Hiller currently serves as executive director. He previously developed antibody-profiling immunoassays while at VBC Genomics in Vienna. 
 
Blackburn, the research director of the CPGR, was recently appointed to a research chair in functional proteomics at the Institute of Infectious Disease and Molecular Medicine at the University of Cape Town beginning in January 2008. He previously served as chief scientist at Procognia, and was the founding scientist and chief scientific officer of Sense Proteomic, a wholly owned subsidiary of Procognia.
 

 
Agendia has named Hessel Lindenbergh chairman of its supervisory board. Lindebergh is chairman of NIB Capital’s supervisory board and is a board member at Royal Numico, Petroplus International, Gamma Holding, and the University Amsterdam

The Scan

Unwrapping Mummies' Faces

LiveScience reports that Parabon NanoLabs researchers have reconstructed how three Egyptian mummies may have looked.

Study on Hold

The Spectrum 10K study has been put on hold due to a backlash, leading the researchers to conduct consultations with the autism community, Nature News reports.

Others Out There Already

Reuters reports that Sanofi is no longer developing an mRNA-based vaccine for SARS-CoV-2.

PNAS Papers on GWAS False Discovery, PRAMEF2 Role in Tumorigenesis, RNA Virus Reverse Genetics

In PNAS this week: strategy to account for GWAS false-discovery rates, role of PRAMEF2 in cancer development, and more.